Ukr.Biochem.J. 2026; Volume 98, Issue 4, Jul-Aug, pp. 5-21

doi: https://doi.org/10.15407/ubj98.04.005

Endothelial glycocalyx integrity in health and disease: molecular mechanisms and stress-related vascular injury

I. S. Fomenko*, V. A. Turkina, T. A. Alyokhina, L. P. Biletska, L. I. Kobylinska

Department of Biochemistry, DNT “Danylo Halytsky Lviv National Medical University”, Ukraine;
*e-mail: iryna.fomenko.lviv@gmail.com

Received: 21 May 2026; Revised: 16 June 2026;
Accepted: 27 July 2026; Available on-line: 04 August 2026

Background. The endothelial glycocalyx (EGX) is a dynamic carbohydrate-rich structure located at the blood-endothelium interface that regulates vascular permeability, mechanotransduction, inflammation, coagulation, and endothelial signaling. Its complex molecular architecture makes the EGX highly susceptible to enzymatic degradation, oxidative stress, and inflammatory mediators, making its disruption a key mechanism of endothelial dysfunction in diverse pathological conditions. Objective. To synthesize current evidence on the molecular architecture of the endothelial glycocalyx, the biochemical mechanisms underlying its degradation, its role in cardiovascular and stress-associated disorders, and emerging glycocalyx-targeted therapeutic strategies. Methods. This integrative review synthesizes evidence from 93 scientific studies identified through a systematic search of ten electronic databases. Results. The analysis demonstrates that glycocalyx degradation contributes to impaired endothelial nitric oxide signaling, increased vascular permeability, endothelial inflammation, and microvascular dysfunction in cardiovascular pathology. Recent evidence further suggests that chronic psychological stress and post-traumatic stress disorder may promote EGX disruption through sustained sympathetic activation, oxidative stress, and low-grade inflammation. The review also discusses therapeutic strategies aimed at preserving or restoring glycocalyx integrity, including inhibition of enzymatic degradation and glycocalyx-targeted regenerative approaches. Conclusions. These findings support a shift toward targeting the glycocalyx as an upstream regulator of vascular health rather than exclusively focusing on downstream vascular complications.

Keywords: , , , ,


References:

  1. Jedlicka J, Becker BF, Chappell D. Endothelial Glycocalyx. Crit Care Clin. 2020;36(2):217-232. PubMed, CrossRef
  2. Kršek A, Batičić L, Ćurko-Cofek B, Batinac T, Laškarin G, Miletić-Gršković S, Sotošek V. Insights into the Molecular Mechanism of Endothelial Glycocalyx Dysfunction during Heart Surgery. Curr Issues Mol Biol. 2024;46(5):3794-3809. PubMed, PubMedCentral, CrossRef
  3. Reitsma S, Slaaf DW, Vink H, van Zandvoort MA, oude Egbrink MG. The endothelial glycocalyx: composition, functions, and visualization. Pflugers Arch. 2007;454(3):345-359. PubMed, PubMedCentral, CrossRef
  4. Ninham BW, Bunkin N, Battye M. The endothelial surface layer-glycocalyx – Universal nano-infrastructure is fundamental to physiology, cell traffic and a complementary neural network. Adv Colloid Interface Sci. 2025;338:103401. PubMed, CrossRef
  5. Annecke T, Fischer J, Hartmann H, Tschoep J, Rehm M, Conzen P, Sommerhoff CP, Becker BF. Shedding of the coronary endothelial glycocalyx: effects of hypoxia/reoxygenation vs ischaemia/reperfusion. Br J Anaesth. 2011;107(5):679-686. PubMed, CrossRef
  6. Becker BF, Chappell D, Jacob M. Endothelial glycocalyx and coronary vascular permeability: the fringe benefit. Basic Res Cardiol. 2010;105(6):687-701. PubMed, CrossRef
  7. Chappell D, Bruegger D, Potzel J, Jacob M, Brettner F, Vogeser M, Conzen P, Becker BF, Rehm M. Hypervolemia increases release of atrial natriuretic peptide and shedding of the endothelial glycocalyx. Crit Care. 2014;18(5):538. PubMed, PubMedCentral, CrossRef
  8. Machin DR, Phuong TT, Donato AJ. The role of the endothelial glycocalyx in advanced age and cardiovascular disease. Curr Opin Pharmacol. 2019;45:66-71. PubMed, PubMedCentral, CrossRef
  9. Milusev A, Rieben R, Sorvillo N. The Endothelial Glycocalyx: A Possible Therapeutic Target in Cardiovascular Disorders. Front Cardiovasc Med. 2022;9:897087. PubMed, PubMedCentral, CrossRef
  10. Edmondson D, Cohen BE. Posttraumatic stress disorder and cardiovascular disease. Prog Cardiovasc Dis. 2013;55(6):548-556. PubMed, PubMedCentral, CrossRef
  11. Passos IC, Vasconcelos-Moreno MP, Costa LG, Kunz M, Brietzke E, Quevedo J, Salum G, Magalhães PV, Kapczinski F, Kauer-Sant’Anna M. Inflammatory markers in post-traumatic stress disorder: a systematic review, meta-analysis, and meta-regression. Lancet Psychiatry. 2015;2(11):1002-1012. PubMed, cr id=”https://doi.org/10.1016/S2215-0366(15)00309-0″]
  12. Zhao X, Yuan W, Wang S, Wu J, Li C. The regulatory effects of serum catecholamines and endothelial cells in pig hemorrhagic shock and fluid resuscitation models. Resusc Plus. 2024;18:100618. PubMed, PubMedCentral, CrossRef
  13. Sidik AI, Dontsov VV, Ruchkin MG, Kapieva NS, Alimagomaev BM, Epimakhova OS, Toktarova NM, Badoyan AA, Falchinsky AN, Kirkevich ND, Kolyada AA. Mechanisms and Clinical Implications of the Post-traumatic Stress Disorder (PTSD)-Cardiovascular Disease Link. Cureus. 2025;17(12):e100349. PubMed, PubMedCentral, CrossRef
  14. Suzuki K, Miura T, Okada H. The endothelial glycocalyx-All the same? No, it is not. Acute Med Surg. 2023;10(1):e896. PubMed, PubMedCentral, CrossRef
  15. Foote CA, Soares RN, Ramirez-Perez FI, Ghiarone T, Aroor A, Manrique-Acevedo C, Padilla J, Martinez-Lemus L. Endothelial Glycocalyx. Compr Physiol. 2022;12(4):3781-3811. PubMed, PubMedCentral, CrossRef
  16. Schwartz NB, Domowicz MS. Proteoglycans in brain development and pathogenesis. FEBS Lett. 2018;592(23):3791-3805. PubMed, CrossRef
  17. Afratis NA, Nikitovic D, Multhaupt HA, Theocharis AD, Couchman JR, Karamanos NK. Syndecans – key regulators of cell signaling and biological functions. FEBS J. 2017;284(1):27-41. PubMed, CrossRef
  18. Diab L, Al Kattar S, Oueini N, Hawi J, Chrabieh A, Dosh L, Jurjus R, Leone A, Jurjus A. Syndecan-1: a key player in health and disease. Immunogenetics. 2024;77(1):9. PubMed, CrossRef
  19. Munesue S, Kusano Y, Oguri K, Itano N, Yoshitomi Y, Nakanishi H, Yamashina I, Okayama M. The role of syndecan-2 in regulation of actin-cytoskeletal organization of Lewis lung carcinoma-derived metastatic clones. Biochem J. 2002;363(Pt 2):201-209. PubMed, PubMedCentral, CrossRef
  20. Chan SJ, Esposito E, Hayakawa K, Mandaville E, Smith RAA, Guo S, Niu W, Wong PT, Cool SM, Lo EH, Nurcombe V. Vascular Endothelial Growth Factor 165-Binding Heparan Sulfate Promotes Functional Recovery From Cerebral Ischemia. Stroke. 2020;51(9):2844-2853. PubMed, CrossRef
  21. Hayashida K, Parks WC, Park PW. Syndecan-1 shedding facilitates the resolution of neutrophilic inflammation by removing sequestered CXC chemokines. Blood. 2009;114(14):3033-3043. PubMed, PubMedCentral, CrossRef
  22. Haynes A 3rd, Ruda F, Oliver J, Hamood AN, Griswold JA, Park PW, Rumbaugh KP. Syndecan 1 shedding contributes to Pseudomonas aeruginosa sepsis. Infect Immun. 2005;73(12):7914-7921. PubMed, PubMedCentral, CrossRef
  23. Voyvodic PL, Min D, Liu R, Williams E, Chitalia V, Dunn AK, Baker AB. Loss of syndecan-1 induces a pro-inflammatory phenotype in endothelial cells with a dysregulated response to atheroprotective flow. J Biol Chem. 2014;289(14):9547-9559. PubMed, PubMedCentral, CrossRef
  24. Vuong TT, Reine TM, Sudworth A, Jenssen TG, Kolset SO. Syndecan-4 is a major syndecan in primary human endothelial cells in vitro, modulated by inflammatory stimuli and involved in wound healing. J Histochem Cytochem. 2015;63(4):280-292. PubMed, PubMedCentral, CrossRef
  25. Dong C, Choi YK, Lee J, Zhang XF, Honerkamp-Smith A, Widmalm G, Lowe-Krentz LJ, Im W. Structure, Dynamics, and Interactions of GPI-Anchored Human Glypican-1 with Heparan Sulfates in a Membrane. Glycobiology. 2021;31(5):593-602. PubMed, PubMedCentral, CrossRef
  26. Thota LNR, Chignalia AZ. The role of the glypican and syndecan families of heparan sulfate proteoglycans in cardiovascular function and disease. Am J Physiol Cell Physiol. 2022;323(4):C1052-C1060. PubMed, CrossRef
  27. Ebong EE, Lopez-Quintero SV, Rizzo V, Spray DC, Tarbell JM. Shear-induced endothelial NOS activation and remodeling via heparan sulfate, glypican-1, and syndecan-1. Integr Biol (Camb). 2014;6(3):338-347. PubMed, PubMedCentral, CrossRef
  28. Askari H, Sadeghinejad M, Fancher IS. Mechanotransduction and the endothelial glycocalyx: Interactions with membrane and cytoskeletal proteins to transduce force. Curr Top Membr. 2023;91:43-60. PubMed, CrossRef
  29. Bartosch AMW, Mathews R, Mahmoud MM, Cancel LM, Haq ZS, Tarbell JM. Heparan sulfate proteoglycan glypican-1 and PECAM-1 cooperate in shear-induced endothelial nitric oxide production. Sci Rep. 2021;11(1):11386. PubMed, PubMedCentral, CrossRef
  30. Qiao D, Yang X, Meyer K, Friedl A. Glypican-1 regulates anaphase promoting complex/cyclosome substrates and cell cycle progression in endothelial cells. Mol Biol Cell. 2008;19(7):2789-2801. PubMed, PubMedCentral, CrossRef
  31. Hayes AJ, Farrugia BL, Biose IJ, Bix GJ, Melrose J. Perlecan, A Multi-Functional, Cell-Instructive, Matrix-Stabilizing Proteoglycan With Roles in Tissue Development Has Relevance to Connective Tissue Repair and Regeneration. Front Cell Dev Biol. 2022;10:856261. PubMed, PubMedCentral, CrossRef
  32. Xie C, Mondal DK, Ulas M, Neill T, Iozzo RV. Oncosuppressive roles of decorin through regulation of multiple receptors and diverse signaling pathways. Am J Physiol Cell Physiol. 2022;322(3):C554-C566. PubMed, PubMedCentral, CrossRef
  33. Feng J, Li Y, Li Y, Yin Q, Li H, Li J, Zhou B, Meng J, Lian H, Wu M, Li Y, Dou K, Song W, Lu B, Liu L, Hu S, Nie Y. Versican Promotes Cardiomyocyte Proliferation and Cardiac Repair. Circulation. 2024;149(13):1004-1015. PubMed, CrossRef
  34. Kunnathattil M, Rahul P, Skaria T. Soluble vascular endothelial glycocalyx proteoglycans as potential therapeutic targets in inflammatory diseases. Immunol Cell Biol. 2024;102(2):97-116. PubMed, CrossRef
  35. Hayes AJ, Melrose J. HS, an Ancient Molecular Recognition and Information Storage Glycosaminoglycan, Equips HS-Proteoglycans with Diverse Matrix and Cell-Interactive Properties Operative in Tissue Development and Tissue Function in Health and Disease. Int J Mol Sci. 2023;24(2):1148. PubMed, PubMedCentral, CrossRef
  36. Alotaibi FS, Alsadun MMR, Alsaiari SA, Ramakrishnan K, Yates EA, Fernig DG. Interactions of proteins with heparan sulfate. Essays Biochem. 2024;68(4):479-489. PubMed, PubMedCentral, CrossRef
  37. Moon JJ, Matsumoto M, Patel S, Lee L, Guan JL, Li S. Role of cell surface heparan sulfate proteoglycans in endothelial cell migration and mechanotransduction. J Cell Physiol. 2005;203(1):166-176. PubMed, CrossRef
  38. Matsuzaka Y, Yashiro R.Classification and Molecular Functions of Heparan Sulfate Proteoglycans and Their Molecular Mechanisms with the Receptor. Biologics. 2024;4(2):105-129. CrossRef
  39. Chai P, Kheiri S, Kuo A, Shah J, Kageler L, Ge R, Perr J, Porat J, Lebedenko CG, Dias JML, Yankova E, Rai SK, Watkins CP, Hristov P, Tzelepis K, Hla T, Raman R, Calo E, Esko JD, Flynn RA. GlycoRNA complexed with heparan sulfate regulates VEGF-A signalling. Nature. 2026;651(8106):808-818. PubMed, PubMedCentral, CrossRef
  40. Florian JA, Kosky JR, Ainslie K, Pang Z, Dull RO, Tarbell JM. Heparan sulfate proteoglycan is a mechanosensor on endothelial cells. Circ Res. 2003;93(10):e136-e142. PubMed, CrossRef
  41. Tao C, Makrides N, Chuang JZ, Wu Y, Brooks SE, Esko JD, Sung CH, Zhang X. Chondroitin sulfate enhances the barrier function of basement membrane assembled by heparan sulfate. Development. 2022;149(12):dev200569. PubMed, PubMedCentral, CrossRef
  42. Ziqin Zhao, Mao Xiaoyan, Jiang Wei, Huang Le Ziqin Zhao, Mao Xiaoyan, Jiang Wei, Huang Le. Keratan Sulfate Promotes Periodontitis Progression Via Tlr4/Nf-Κb Pathway. Int Dental J. 2025;75(1):104713. CrossRef
  43. Lierova A, Kasparova J, Filipova A, Cizkova J, Pekarova L, Korecka L, Mannova N, Bilkova Z, Sinkorova Z. Hyaluronic Acid: Known for Almost a Century, but Still in Vogue. Pharmaceutics. 2022;14(4):838. PubMed, PubMedCentral, CrossRef
  44. McDonald B, Kubes P. Interactions between CD44 and Hyaluronan in Leukocyte Trafficking. Front Immunol. 2015;6:68. PubMed, PubMedCentral, CrossRef
  45. Vittum Z, Cocchiaro S, Mensah SA. Basal endothelial glycocalyx’s response to shear stress: a review of structure, function, and clinical implications. Front Cell Dev Biol. 2024;12:1371769. PubMed, PubMedCentral, CrossRef
  46. Jin J, Fang F, Gao W, Chen H, Wen J, Wen X, Chen J. The Structure and Function of the Glycocalyx and Its Connection With Blood-Brain Barrier. Front Cell Neurosci. 2021;15:739699. PubMed, PubMedCentral, CrossRef
  47. Peterson JM, Smith TA, Rock EP, Magnani JL. Selectins in Biology and Human Disease: Opportunity in E-selectin Antagonism. Cureus. 2024;16(6):e61996. PubMed, PubMedCentral, CrossRef
  48. Yilmaz O, Afsar B, Ortiz A, Kanbay M. The role of endothelial glycocalyx in health and disease. Clin Kidney J. 2019;12(5):611-619. PubMed, PubMedCentral, CrossRef
  49. Zhang J. Biomarkers of endothelial activation and dysfunction in cardiovascular diseases. Rev Cardiovasc Med. 2022;23(2):73. PubMed, CrossRef
  50. Rubinelli L, Manzo OL, Sungho J, Del Gaudio I, Bareja R, Marino A, Palikhe S, Di Mauro V, Bucci M, Falcone DJ, Elemento O, Ersoy B, Diano S, Sasset L, Di Lorenzo A. Suppression of endothelial ceramide de novo biosynthesis by Nogo-B contributes to cardiometabolic diseases. Nat Commun. 2025;16(1):1968. PubMed, PubMedCentral, CrossRef
  51. Dancy C, Heintzelman KE, Katt ME. The Glycocalyx: The Importance of Sugar Coating the Blood-Brain Barrier. Int J Mol Sci. 2024;25(15):8404. PubMed, PubMedCentral, CrossRef
  52. Gomez Toledo A, Golden GJ, Cummings RD, Malmström J, Esko JD. Endothelial Glycocalyx Turnover in Vascular Health and Disease: Rethinking Endothelial Dysfunction. Annu Rev Biochem. 2025;94(1):561-586. PubMed, CrossRef
  53. Delgadillo LF, Marsh GA, Waugh RE. Endothelial Glycocalyx Layer Properties and Its Ability to Limit Leukocyte Adhesion. Biophys J. 2020;118(7):1564-1575. PubMed, PubMedCentral, CrossRef
  54. Ferreira G, Taylor A, Mensah SA. Deciphering the triad of endothelial glycocalyx, von Willebrand Factor, and P-selectin in inflammation-induced coagulation. Front Cell Dev Biol. 2024;12:1372355. PubMed, PubMedCentral, CrossRef
  55. Ćurko-Cofek B, Jenko M, Taleska Stupica G, Batičić L, Krsek A, Batinac T, Ljubačev A, Zdravković M, Knežević D, Šoštarič M, Sotošek V. The Crucial Triad: Endothelial Glycocalyx, Oxidative Stress, and Inflammation in Cardiac Surgery-Exploring the Molecular Connections. Int J Mol Sci. 2024;25(20):10891. PubMed, PubMedCentral, CrossRef
  56. Abassi Z, Armaly Z, Heyman SN. Glycocalyx Degradation in Ischemia-Reperfusion Injury. Am J Pathol. 2020;190(4):752-767. PubMed, CrossRef
  57. Chen P, Abacherli LE, Nadler ST, Wang Y, Li Q, Parks WC. MMP7 shedding of syndecan-1 facilitates re-epithelialization by affecting alpha(2)beta(1) integrin activation. PLoS One. 2009;4(8):e6565. PubMed, PubMedCentral, CrossRef
  58. Ramnath RD, Butler MJ, Newman G, Desideri S, Russell A, Lay AC, Neal CR, Qiu Y, Fawaz S, Onions KL, Gamez M, Crompton M, Michie C, Finch N, Coward RJ, Welsh GI, Foster RR, Satchell SC. Blocking matrix metalloproteinase-mediated syndecan-4 shedding restores the endothelial glycocalyx and glomerular filtration barrier function in early diabetic kidney disease. Kidney Int. 2020;97(5):951-965. PubMed, PubMedCentral, CrossRef
  59. Ali MM, Mahmoud AM, Le Master E, Levitan I, Phillips SA. Role of matrix metalloproteinases and histone deacetylase in oxidative stress-induced degradation of the endothelial glycocalyx. Am J Physiol Heart Circ Physiol. 2019;316(3):H647-H663. PubMed, PubMedCentral, CrossRef
  60. Anand T, Reyes AA, Sjoquist MC, Magnotti L, Joseph B. Resuscitating the Endothelial Glycocalyx in Trauma and Hemorrhagic Shock. Ann Surg Open. 2023;4(3):e298. PubMed, PubMedCentral, CrossRef
  61. Barry M, Pati S. Targeting repair of the vascular endothelium and glycocalyx after traumatic injury with plasma and platelet resuscitation. Matrix Biol Plus. 2022;14:100107. PubMed, PubMedCentral, CrossRef
  62. Johansson PI, Stensballe J, Rasmussen LS, Ostrowski SR. A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients. Ann Surg. 2011;254(2):194-200. PubMed, CrossRef
  63. Masola V, Greco N, Gambaro G, Franchi M, Onisto M. Heparanase as active player in endothelial glycocalyx remodeling. Matrix Biol Plus. 2021;13:100097. PubMed, PubMedCentral, CrossRef
  64. Suzuki A, Tomita H, Okada H. Form follows function: The endothelial glycocalyx. Transl Res. 2022;247:158-167. PubMed, CrossRef
  65. Iba T, Levy JH. Derangement of the endothelial glycocalyx in sepsis. J Thromb Haemost. 2019;17(2):283-294. PubMed, CrossRef
  66. Franceković P, Gliemann L. Endothelial Glycocalyx Preservation-Impact of Nutrition and Lifestyle. Nutrients. 2023;15(11):2573. PubMed, PubMedCentral, CrossRef
  67. Lipowsky HH. The endothelial glycocalyx as a barrier to leukocyte adhesion and its mediation by extracellular proteases. Ann Biomed Eng. 2012;40(4):840-848. PubMed, PubMedCentral, CrossRef
  68. Ghondaghsaz E, Khalaji A, Norouzi M, Fraser DD, Alilou S, Behnoush AH. The utility of syndecan-1 circulating levels as a biomarker in patients with previous or active COVID-19: a systematic review and meta-analysis. BMC Infect Dis. 2023;23(1):510. PubMed, PubMedCentral, CrossRef
  69. Komisarenko SV. Scientist’s pursuit for coronavirus SARS-COV-2, which causes COVID-19: scientific strategies against pandemic. Visnyk Nat Acad Sci Ukraine. 2020;(8):29-71. (In Ukrainian). CrossRef
  70. Pokrovska N, Denysenko N, Fomenko I, Sklyarova H, Basylevych A, Sklyarov E, Vari SG, Kobylinska L. Galectin-3 in Blood Serum and Lymphocytes as a Marker of Myocardial Damage in Patients with Arterial Hypertension and COVID-19. Antiinflamm Antiallergy Agents Med Chem. 2023;22(4):250-260. PubMed, CrossRef
  71. Banerjee S, Mwangi JG, Stanley TK, Mitra R, Ebong EE. Regeneration and Assessment of the Endothelial Glycocalyx To Address Cardiovascular Disease. Ind Eng Chem Res. 2021; 60(48): 17328-17347. CrossRef
  72. Ahn SJ, Le Master E, Granados ST, Levitan I. Impairment of endothelial glycocalyx in atherosclerosis and obesity. Curr Top Membr. 2023;91:1-19. PubMed, PubMedCentral, CrossRef
  73. Mitra R, O’Neil GL, Harding IC, Cheng MJ, Mensah SA, Ebong EE. Glycocalyx in Atherosclerosis-Relevant Endothelium Function and as a Therapeutic Target. Curr Atheroscler Rep. 2017;19(12):63. PubMed, PubMedCentral, CrossRef
  74. Li T, Liu X, Zhao Z, Ni L, Liu C. Sulodexide recovers endothelial function through reconstructing glycocalyx in the balloon-injury rat carotid artery model. Oncotarget. 2017;8(53):91350-91361. PubMed, PubMedCentral, CrossRef
  75. Lagrange J, Jahangiri M, Baudry G, Monzo L, Guerci P, Ter Maaten JM, Heymans S, Mercier N, Girerd N. Updates on the endothelial glycocalyx in heart failure with preserved ejection fraction. Am J Physiol Heart Circ Physiol. 2025;329(5):H1316-H1330. PubMed, CrossRef
  76. Lagrange J, Jahangiri M PhD, Baudry G, Mercier N, Monzo L, Lamiral Z, Duarte K, Ter Maaten JM, Zannad F, Voors AA, Girerd N. Association Between Endothelial Alterations, Cardiac Function, and Outcomes From Health to Heart Failure: Insight From the STANISLAS, MEDIA-DHF, and BIOSTAT-CHF Cohorts. J Am Heart Assoc. 2025;14(11):e040179. PubMed, PubMedCentral, CrossRef
  77. Kitagawa Y, Kawamura I, Suzuki K, Okada H, Ishihara T, Tomita H, Suzuki K, Takada C, Sampei S, Kano S, Kondo K, Asano H, Wakayama Y, Kamidani R, Kawasaki Y, Fukuda H, Nishio A, Miyake T, Fukuta T, Yasuda R, Oiwa H, Kakino Y, Miyazaki N, Watanabe T, Yoshida T, Doi T, Suzuki A, Yoshida S, Matsuo H, Ogura S. Serum syndecan-1 concentration in hospitalized patients with heart failure may predict readmission-free survival. PLoS One. 2021;16(12):e0260350. PubMed, PubMedCentral, CrossRef
  78. Wadowski PP, Hülsmann M, Lang IM, Schörgenhofer C, Pultar J, Weikert C, Gremmel T, Steiner S, Koppensteiner R, Kopp CW, Jilma B. Glycocalyx Disintegration Is Associated with Mortality in Chronic Heart Failure. Clin Med. 2025;14(10):3571. PubMed, PubMedCentral, CrossRef
  79. Tuomisto K, Jousilahti P, Sundvall J, Pajunen P, Salomaa V. C-reactive protein, interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality. A population-based, prospective study. Thromb Haemost. 2006;95(3):511-518. PubMed, CrossRef
  80. Yang L, Xing W, Shi Y, Hu M, Li B, Hu Y, Zhang G. Stress-induced NLRP3 inflammasome activation and myelin alterations in the hippocampus of PTSD rats. Neuroscience. 2024;555:156-166. PubMed, CrossRef
  81. Johansson PI, Henriksen HH, Stensballe J, Gybel-Brask M, Cardenas JC, Baer LA, Cotton BA, Holcomb JB, Wade CE, Ostrowski SR. Traumatic Endotheliopathy: A Prospective Observational Study of 424 Severely Injured Patients. Ann Surg. 2017;265(3):597-603. PubMed, PubMedCentral, CrossRef
  82. Nelson A, Berkestedt I, Schmidtchen A, Ljunggren L, Bodelsson M. Increased levels of glycosaminoglycans during septic shock: relation to mortality and the antibacterial actions of plasma.
    Shock. 2008;30(6):623-627. PubMed, CrossRef
  83. Krištić J, Vučković F, Menni C, Klarić L, Keser T, Beceheli I, Pučić-Baković M, Novokmet M, Mangino M, Thaqi K, Rudan P, Novokmet N, Sarac J, Missoni S, Kolčić I, Polašek O, Rudan I, Campbell H, Hayward C, Aulchenko Y, Valdes A, Wilson JF, Gornik O, Primorac D, Zoldoš V, Spector T, Lauc G. Glycans are a novel biomarker of chronological and biological ages. J Gerontol A Biol Sci Med Sci. 2014;69(7):779-789. PubMed, PubMedCentral, CrossRef
  84. Rapčan B, Song M, Frkatović-Hodžić A, Pribić T, Vuk J, Beletić A, Hanić M, Jurić J, Tominac P, Milas J, Ivić V, Viland S, Bonet S, Šego B, Heffer M, Wang W, Snyder MP, Lauc G. Glycan clock of ageing-analytical precision and time-dependent inter- and i-individual variability. Geroscience. 2024;46(6):5781-5796. PubMed, PubMedCentral, CrossRef
  85. Tudor L, Nedic Erjavec G, Nikolac Perkovic M, Konjevod M, Svob Strac D, Uzun S, Kozumplik O, Jovanovic T, Lauc G, Pivac N. N-glycomic Profile in Combat Related Post-Traumatic Stress Disorder. Biomolecules. 2019;9(12):834. PubMed, PubMedCentral, CrossRef
  86. Vari SG. Healing Ukrainian Wounded Soldiers. Ukr Biochem J. 2023;95(3):3-4. CrossRef
  87. Inoda A, Suzuki K, Tomita H, Okada H. Glycocalyx shedding as a clinical biomarker in critical illness. Exp Mol Pathol. 2025;144:104997. PubMed, CrossRef
  88. Wyss LC, Freeman SA.The Glycocalyx: Barriers and Opportunities at Cell–Cell Encounters. Proteoglycan Res. 2025;3(4): e70040. CrossRef
  89. Mitra R, Pentland K, Kolev S, Eden M, Levine E, Oakes JM, Ebong EE. Co-therapy with S1P and heparan sulfate derivatives to restore endothelial glycocalyx and combat pro-atherosclerotic endothelial dysfunction. Life Sci. 2025;377:123662. PubMed, CrossRef
  90. Broekhuizen LN, Lemkes BA, Mooij HL, Meuwese MC, Verberne H, Holleman F, Schlingemann RO, Nieuwdorp M, Stroes ES, Vink H. Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus. Diabetologia. 2010;53(12):2646-2655. PubMed, PubMedCentral, CrossRef
  91. Ying J, Zhang C, Wang Y, Liu T, Yu Z, Wang K, Chen W, Zhou Y, Lu G. Sulodexide improves vascular permeability via glycocalyx remodelling in endothelial cells during sepsis. Front Immunol. 2023;14:1172892. PubMed, PubMedCentral, CrossRef
  92. Jiang YH, Li XJ, Ma DC, Chen YL, Shi YY, Lu Y, Mao RF. Endothelial barrier and sepsis: mechanisms and potential therapeutic strategies. Mil Med Res. 2026;13(1):100013. PubMed, PubMedCentral, CrossRef
  93. Locatelli M, Rottoli D, Mahmoud R, Abbate M, Corna D, Cerullo D, Tomasoni S, Remuzzi G, Zoja C, Benigni A, Macconi D. Endothelial Glycocalyx of Peritubular Capillaries in Experimental Diabetic Nephropathy: A Target of ACE Inhibitor-Induced Kidney Microvascular Protection. Int J Mol Sci. 2023;24(22):16543. PubMed, PubMedCentral, CrossRef

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License.